Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00891982 · ClinicalTrials.gov registry record · Phase 3
A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash
A Phase 3 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
NCT00891982 is a Phase 3 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 60 participants.
The verdict
NCT00891982, a Phase 3 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the tolerability of a combined regimen of a topical antibiotic and retinoid and a benzoyl peroxide wash.
Interventions
- DRUG CTGel/ BPO Wash
- DRUG Soap Free Cleanser and CTGel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2009-04-01 |
| Est. Completion | 2009-06-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00891982
The ClinicalTrials.gov registry entry for NCT00891982 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stiefel, a GSK Company, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CTGel/ BPO Wash is the first listed.
NCT00891982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00891982 about?
NCT00891982 is a clinical study titled "A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash". The purpose of this study is to evaluate the tolerability of a combined regimen of a topical antibiotic and retinoid and a benzoyl peroxide wash.
What is the current status of trial NCT00891982?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2009-04-01. Estimated completion is 2009-06-05.
What interventions are being tested in trial NCT00891982?
The interventions under investigation include: CTGel/ BPO Wash (DRUG), Soap Free Cleanser and CTGel (DRUG).
Who is sponsoring clinical trial NCT00891982?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.